🔎 Trials Near Me

Inicio › Cáncer de pulmón › Utah

Ensayos clínicos de Cáncer de pulmón en Utah

22 estudios sobre Cáncer de pulmón buscan participantes en Utah.

Ciudades en Utah

Texto oficial del estudio (inglés)

A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07458347

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

  • Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07020221

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • START Mountain Region, West Valley City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06400472

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

  • Utah Cancer Specialists, Salt Lake City
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • University of Utah, Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

  • Avenzo Therapeutics Recruiting Site, West Valley City
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2
18 Minutes · Todos los sexos · Actualizado el 9 oct 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 oct 2026 · NCT06616584

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 oct 2026 · NCT07222566

SPARC - Screening for Lung Cancer With Platelets Via an AI-enabled RNA-based Classifier

  • University of Utah, Salt Lake City
  • Veterans Affairs SLC Health Care System (VAMC), Salt Lake City
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 21 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07460440

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06343402

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT06500481

Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics

  • Huntsman Cancer Institute/ University of Utah, Salt Lake City
ReclutandoSe aceptan voluntarios sanos
Edades de 50 a 80 · Todos los sexos · Actualizado el 21 jul 2026 · NCT07716280

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT05642572

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

  • START Mountain Region, West Valley City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 may 2026 · NCT07223047

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Huntsman Cancer Institute, Salt Lake City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 may 2026 · NCT05379985

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT05297734

Improving Care for Rural Patients With Solid Tumors

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Reclutando
Edades de 18 a 99 · Todos los sexos · Actualizado el 5 feb 2026 · NCT04916990

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.